b'M E D I A PARTNERSTo those who say impossible, impractical, unrealistic, we say CHALLENGE ACCEPTED Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into anentirely new class of medicines, which we believe has the potential to help people all over the world to live longer, healthier, and fuller lives. For people like Ania.Congratulations to our HBA 2022 LuminaryCarol Pitcher-Towner, withadmiration and appreciation. 2022 Alnylam Pharmaceuticals, Inc. Ania, living with a rare disease'